ImmuPharma plc Share Price
Stocks
IMM
GB0033711010
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
London S.E.
12:54:00 05/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 3.400 GBX | +3.03% |
|
+3.03% | -45.16% |
| 24/09 | WINNERS & LOSERS: Quantum Data restored; Asos upbeat on outlook | AN |
| 18/09 | WINNERS & LOSERS: Mothercare review; Dianomi agrees acquisition | AN |
| Market Cap | 2.06Cr 2.73Cr 2.43Cr 2.26Cr 3.89Cr 262.44Cr 3.93Cr 27Cr 11Cr 134.16Cr 10Cr 10Cr 430.58Cr | P/E 2024 |
-2.01x | P/E 2025 | -16.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.93Cr 2.55Cr 2.27Cr 2.12Cr 3.64Cr 245.24Cr 3.67Cr 26Cr 9.92Cr 125.37Cr 9.58Cr 9.37Cr 402.36Cr | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
95.04% | Yield 2024 * |
-
| Yield 2025 | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| IMM | Delayed | |
Deutsche Boerse AG
| 25I | Delayed | |
|
Börse Stuttgart
| 25I | Delayed | |
|
Boerse Muenchen
| 25I | Real-time | |
|
CBOE
| IMM | Real-time |
Last Transcript: ImmuPharma plc
| 1 day | +3.03% | ||
| 1 week | +3.03% | ||
| Current month | +4.62% | ||
| 1 month | -15.00% | ||
| 3 months | -9.21% | ||
| 6 months | -25.11% | ||
| Current year | -45.16% |
| 1 week | 3.2 |  | 3.8 |
| 1 month | 3.02 | | 4.1 |
| Current year | 3.02 | | 11 |
| 1 year | 3.02 | | 14 |
| 3 years | 0.82 | | 19.4 |
| 5 years | 0.82 | | 19.4 |
| 10 years | 0.82 | | 193.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 70 | 30/07/2021 | |
Ashley Clarke
DFI | Director of Finance/CFO | - | 03/12/2024 |
| Chief Tech/Sci/R&D Officer | - | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Lisa Baderoon
BRD | Director/Board Member | 60 | 29/07/2021 |
| Chairman | 70 | 30/09/2015 | |
Timothy Franklin
BRD | Director/Board Member | 62 | 16/07/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/04/24 | Free | Director | 30,00,000 | 0.7204% | ||
| 19/04/24 | Free | Director | 20,00,000 | 0.4803% | ||
| 22/12/22 | Free | Chief Executive Officer | 18,00,000 | 0.5399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.03% | +3.03% | -69.37% | +85.79% | 2.73Cr | |
| +4.16% | +3.04% | +49.37% | +94.17% | 7.42TCr | |
| +0.29% | -3.17% | +20.30% | +79.30% | 5.74TCr | |
| +0.53% | -2.36% | +2.37% | +35.84% | 4.76TCr | |
| +0.36% | +0.81% | +342.39% | +748.97% | 4.43TCr | |
| -0.96% | -4.50% | +24.96% | +31.45% | 4.25TCr | |
| -0.20% | -0.77% | +4.13% | +111.69% | 4.07TCr | |
| -0.54% | +2.93% | +9.31% | +54.06% | 3.1TCr | |
| +1.28% | +3.56% | +31.67% | +28.90% | 2.85TCr | |
| +0.05% | -1.64% | -8.14% | -12.10% | 2.43TCr | |
| Average | +0.81% | -0.44% | +40.70% | +125.81% | 3.91TCr | |
| Weighted average by Cap. | +0.87% | -0.84% | +57.16% | +139.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -24.83L -32.86L -29.19L -27.25L -46.84L -32Cr -47.27L -3.3Cr -1.28Cr -16Cr -1.23Cr -1.21Cr -52Cr | -18.08L -23.92L -21.25L -19.83L -34.09L -23Cr -34.41L -2.4Cr -93L -12Cr -89.79L -87.84L -38Cr |
| Net Debt | -2L -3L -3L -3L -4L -3.01Cr -5L -31.45L -12.19L -1.54Cr -11.77L -11.51L -4.94Cr | -13.52L -17.89L -15.9L -14.84L -25.5L -17Cr -25.74L -1.8Cr -69.57L -8.79Cr -67.17L -65.71L -28Cr |
Employees
7
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | GBX 3.400 | +3.03% | 1,98,669 |
| 02/26/02 | GBX 3.300 | -5.58% | 29,91,041 |
| 01/26/01 | GBX 3.495 | +7.54% | 11,78,422 |
| 30/26/30 | GBX 3.250 | -0.15% | 19,88,517 |
| 29/26/29 | GBX 3.255 | -1.36% | 6,66,272 |
- Stock Market
- Stocks
- IMM Stock
Select your edition
All financial news and data tailored to specific country editions
